NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (“Lemonade”) today announced the pricing of its initial public offering of 11,000,000 shares of its common stock at a price of $29.00 per share. Lemonade has granted the underwriters a 30-day option to purchase up to...

LAS VEGAS–(BUSINESS WIRE)–Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae”) today announced that Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet”), a Cannae portfolio company, priced its initial public offering of 78,302,272 shares of its common stock at an initial public offering price...

NEW YORK–(BUSINESS WIRE)–Panacea Acquisition Corp. (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the pricing...

NEW YORK–(BUSINESS WIRE)–GS Acquisition Holdings Corp II (the “Company”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced...

WHEATON, Ill.–(BUSINESS WIRE)–First Trust Advisors L.P. (“First Trust”), a registered investment adviser, is pleased to announce the initial public offering of the First Trust High Yield Opportunities 2027 Term Fund (the “Fund”), a newly organized, diversified, closed-end fund that seeks...

NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (“Lemonade”) today announced that it has commenced the initial public offering of its common stock. Lemonade is offering 11,000,000 shares of its common stock. The initial public offering is expected to be between $23.00 and $26.00...

LAS VEGAS–(BUSINESS WIRE)–Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae”) today announced that Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet”), a Cannae portfolio company, launched its initial public offering of 65,750,000 shares of its common stock at an anticipated initial public offering...

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced the closing of its previously announced upsized initial public...

WATERTOWN, Mass.–(BUSINESS WIRE)–Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of its initial public offering of 15,964,704 shares of common stock, including the exercise in full by...

NEW YORK–(BUSINESS WIRE)–Trebia Acquisition Corp. (the “Company”) (NYSE: TREB.U) today announced the closing of its initial public offering of 51,750,000 units, which includes 6,750,000 units issued upon the exercise of the underwriters’ overallotment option, which was exercised in full, at...